Zweegman S, van der Holt B, Mellqvist UH, et al. Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma. Blood. 2016 Mar 3;127(9):1109-16.,Stege C, Kongsgaard Nielsen L, Witte B, et al. Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma; results of the HOVON87/NMSG18 study. EHA 2017, abstract S501.
NFK: zelfs 10 jaar na diagnose kanker nog steeds klachten
feb 2024 | Borstkanker, Leukemie, Lymfoom, Uro-oncologie